Before the seal’s initial opening, the user reads the NFC chip using a smartphone and related app to receive confirmation of the product’s authenticity. The closure seal with a void effect and an integrated NFC chip combines analog and digital technologies, offering double tamper evidence. Due to its small size, the cost-efficient authentication technology can be easily integrated into existing packaging or label designs. The pattern can be authenticated quickly and flexibly on-site using a smartphone or handheld reader, and analyzed via related software. In an attempt to copy the small random pattern, whose size is just a few millimeters, the printed image suffers a loss in precision and optical details. Schreiner MediPharm noted smart packaging builds a digital bridge between manufacturers, distributors and patients by opening new platforms of communication between them, with pharmaceutical packaging of the future needing to be about more than marking and protecting medicines.īy showcasing authentication and tamper evidence, Schreiner MediPharm and Edelmann identified how they have shown pharmaceutical manufacturers the possibilities for supply chain security and compliance with the EU Falsified Medicines Directives, which has been in effect since February 2019.īitSecure copy detection technology is a printed, digital security feature based on a high-resolution, random pattern whose intricate details are not discernible by the naked eye. The result is a smart medicine packaging option featuring digital features such as BitSecure copy detection technology, as well as a closure seal with integrated NFC chip and void effect for tamper evidence.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |